Jeffrey A. Hubbell, Ph.D.

Affiliations: 
2003 Eidgenössische Technische Hochschule Zürich, Zürich, ZH, Switzerland 
 2003-2014 École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland 
 2014- University of Chicago, Chicago, IL 
Area:
biomaterials and protein engineering
Website:
https://newfaculty.uchicago.edu/page/jeffrey-hubbell
Google:
"Jeffrey Hubbell"
Bio:

http://www.nae.edu/MembersSection/Directory20412/31121.aspx?layoutChange=Print,LowGraphics

Mean distance: 8.07
 
SNBCP

Parents

Sign in to add mentor
Larry V. McIntire grad student 1986 Rice University
 (Visualization and Analysis of Mural Thrombogenesis (Platelet Adhesion, Collagen, Polyurethane, Digital Image Processing))

Children

Sign in to add trainee
Donald L. Elbert grad student (BME Tree)
Matthias P. Lutolf grad student ETH Zürich
William R. Wagner grad student (BME Tree)
Jennifer L. West grad student 1992-1996 UT Austin
Shelly E. Sakiyama-Elbert grad student 1996-2000 Caltech (BME Tree)
Philipp J. Thurner grad student 2000-2004 ETH Zürich | University of Zürich
Anna Leonidova grad student 2010 EPFL
Shijie Cao post-doc
Weiyuan J. Kao post-doc ETH Zürich
Tatiana Segura post-doc (BME Tree)
Heather Dawn Maynard post-doc 2000-2002 ETH Zürich
Evan A. Scott post-doc 2009-2013 EPFL (BME Tree)
Edward A. Phelps post-doc 2012-2016 EPFL
Nicola Tirelli research scientist 1998-2002 ETH Zürich
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kang S, Mansurov A, Kurtanich T, et al. (2023) Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Science Advances. 9: eadh9879
Goldberger Z, Hauert S, Chang K, et al. (2023) Membrane-localized neoantigens predict the efficacy of cancer immunotherapy. Cell Reports. Medicine. 4: 101145
Slezak AJ, Mansurov A, Raczy MM, et al. (2022) Tumor Cell-Surface Binding of Immune Stimulating Polymeric Glyco-Adjuvant via Cysteine-Reactive Pyridyl Disulfide Promotes Antitumor Immunity. Acs Central Science. 8: 1435-1446
Briquez PS, Rouhani SJ, Yu J, et al. (2022) Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science Advances. 8: eabn3777
Mansurov A, Hosseinchi P, Chang K, et al. (2022) Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nature Biomedical Engineering
Briquez PS, Rouhani SJ, Yu J, et al. (2021) SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II. Medrxiv : the Preprint Server For Health Sciences
Yu SS, Hubbell JA, Swartz MA. (2021) Overcoming transport barriers to immunotherapy. Drug Delivery and Translational Research. 11: 2273-2275
Gray LT, Raczy MM, Briquez PS, et al. (2021) Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant. Biomaterials. 278: 121159
Maulloo CD, Cao S, Watkins EA, et al. (2021) Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance. Frontiers in Immunology. 12: 714842
Volpatti LR, Wallace RP, Cao S, et al. (2021) Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity. Acs Central Science. 7: 1368-1380
See more...